L-DOPA Decarboxylase Association with Membranes in Mouse Brain

被引:0
|
作者
Poulikos Poulikakos
Dido Vassilacopoulou
Emmanuel G. Fragoulis
机构
[1] University of Athens,Department of Biochemistry and Molecular Biology
来源
Neurochemical Research | 2001年 / 26卷
关键词
L-DOPA decarboxylase; mouse brain; membranes; Triton X-114; phosphatidylinositol-specific phospholipase C;
D O I
暂无
中图分类号
学科分类号
摘要
This work presents evidence on the association of active DDC molecules with membranes in mammalian brain. L-DOPA decarboxylase (DDC) is generally considered to be a cytosolic enzyme. Membrane-associated DDC was detected by immunoblotting and enzymatic assay experiments. DDC activity and immunoreactivity could be partially extracted from mammalian brain membranes by detergent. Fractionation of membranes by temperature-induced phase separation in Triton X-114, resulted in the recovery of membrane-associated DDC in separation phases where integral and hydrophobic membrane proteins separate. Treatment of membranes with phosphatidylinositol-specific phospholipase C or proteinase K, did not elute membrane-associated DDC activity, suggesting that a population of DDC molecules exist embedded within membranes. The elucidation of the functional significance of the enzyme's association with membranes could provide us with new information leading to the better understanding of the biological pathways that DDC is involved in.
引用
收藏
页码:479 / 485
页数:6
相关论文
共 50 条
  • [11] L-dopa attenuates the cytokine production in the mouse brain
    Sugino, Yuta
    Yoshioka, Yasuhiro
    Yamada, Joe
    Yamashita, Kazumi
    Tamura, Manami
    Yamamuro, Akiko
    Ishimaru, Yuki
    Maeda, Sadaaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S158 - S158
  • [12] PARKINSONIAN SYNDROMES - TREATMENT BY ASSOCIATION OF L-DOPA PLUS DECARBOXYLASE INHIBITOR
    GAUTHIER, G
    JUGE, O
    BIRCHLER, A
    EUROPEAN NEUROLOGY, 1974, 11 (03) : 133 - 157
  • [13] PARKINSONS DISEASE - ACTIVITY OF L-DOPA DECARBOXYLASE IN DISCRETE BRAIN REGIONS
    LLOYD, K
    HORNYKIEWICZ, O
    SCIENCE, 1970, 170 (3963) : 1212 - +
  • [14] TREATMENT OF PARKINSONS DISEASE - COMPARISON OF L-DOPA AND A COMBINATION OF L-DOPA AND DECARBOXYLASE INHIBITOR
    GORLICH, J
    MARKUS, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (34) : 1246 - &
  • [15] ENHANCEMENT OF L-DOPA INCORPORATION INTO MELANOMA BY DOPA DECARBOXYLASE INHIBITION
    WICK, MM
    KRAMER, RA
    GORMAN, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1978, 70 (06) : 358 - 360
  • [16] SUBSTITUTION THERAPY IN PARKINSONISM - L-DOPA, L-DOPA AND DECARBOXYLASE INHIBITOR OR 3-O-METHYL DOPA
    GAUTHIER, G
    AJURIAGU.JD
    GEISSBUHLER, F
    SIMONA, B
    CONSTANTINIDIS, J
    YANNIOTIS, G
    KRASSOIEVITCH, M
    EISENRING, JJ
    TISSOT, R
    PRESSE MEDICALE, 1971, 79 (03): : 91 - +
  • [17] L-DOPA PLUS DECARBOXYLASE INHIBITOR IN DEPRESSION
    MATUSSEK, N
    BENKERT, O
    SCHNEIDER, K
    OTTEN, H
    POHLMEIER, H
    LANCET, 1970, 2 (7674): : 660 - +
  • [18] Kinetic Isotope Effects of L-Dopa Decarboxylase
    Lin, Yen-lin
    Gao, Jiali
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (12) : 4398 - 4403
  • [19] Evidence for the implication of L-Dopa decarboxylase in apoptosis
    Tsakou, A. C.
    Chalatsa, I.
    Fragoulis, E. G.
    Vassilacopoulou, D.
    FEBS JOURNAL, 2013, 280 : 429 - 429
  • [20] GOUT INDUCED BY L-DOPA AND DECARBOXYLASE INHIBITORS
    CALNE, DB
    FERMAGLICH, J
    POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (606) : 232 - 233